Harsh K.

Harsh K. is a seasoned professional in regulatory affairs with extensive experience in the pharmaceutical industry. Currently serving as a Regulatory Affairs Manager at Taro Pharmaceuticals Canada since July 2019, Harsh has a strong background in drug product submissions for Canada and the U.S. Previously held positions include Senior Regulatory Affairs Executive at Sun Pharma, where complex pharmaceutical preparations were submitted internationally, and Executive-Regulatory Affairs roles at Ipca Laboratories Limited and Sterling Biotech Limited, focusing on ANDA submissions and API registration. Harsh began career in quality assurance as a Senior Quality Assurance Officer at Intas Pharmaceuticals and has progressively developed expertise in regulatory processes. Harsh holds a Master of Pharmacy in Pharmaceutics and Drug Design from SVKM's Narsee Monjee Institute of Management Studies and certification in Pharmaceutical Regulatory Affairs from the Bioinformatics Institute of India.